Thanks!
ScottW
Transplant immunosuppressant drugs to remain a Medicare Part D benefit >
CMS announced that it would retain the existing “protected class” status for immunosuppressant medications available as a benefit under Medicare Part D coverage.
Average Daily Organ Placement On The Rise >
During April, staff of the UNOS Organ Center helped the transplant community place an average of 38.5 organs per day—an all-time monthly record..
OPTN/UNOS leadership briefs Congressional staff members on key policy issues >
On May 21, UNOS Chief Executive Officer Brian Shepard and chairs of three OPTN/UNOS committees briefed staff members of the Congress of the United States on policy issues under discussion or implementation.
Infections and immunity >
There are three general time frames during which infection can occur in the post-transplant period: first month, second through sixth month, and after the sixth month.
Urine test improves detection of alcohol use in liver transplant patients >
When used together, urinary ethyl glucuronide (uEtG) and the Alcohol Use Disorders Identification Test for alcohol consumption (AUDIT-c) improve the detection of alcohol consumption in liver transplant candidates and recipients, according to a recent study.
Transplant immunosuppressant sirolimus may reduce HIV persistence >
HIV persistence is reduced in association with immunosuppressants, especially sirolimus, used after kidney transplantation, according to results from the Solid Organ Transplantation in HIV: Multi-Site Study. |